Joseph K. Schachle, Chief Operating Officer at Ocuphire Pharma, Inc. (OCUP), bought 2,000 shares at $2.05 ($4K) on 2024-03-21, disclosed to the SEC on 2024-03-25.
Open-market purchase of $4k OCUP by Chief Operating Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| IRD | SELL | 2026-03-18 | $39K | — | Filing → |